Overview
Atorvia’s purpose is to transform outcomes for patients with severe medical conditions. Our initial focus is acute kidney injury (AKI), a devastating condition which affects millions worldwide yet still lacks effective therapy. To address this crisis, we are developing a kidney-targeted peptide that prevents regulated cell death and kidney failure.